✦ LIBER ✦

Hormone Replacement Therapy Formulations and Risk of Epithelial Ovarian Carcinoma

✍ Scribed by Anita S.Y Sit; Francesmary Modugno; Joel L Weissfeld; Sarah L Berga; Roberta B Ness

Book ID: 112251899
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 51 KB
Volume: 86
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.2002.6746

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone replacement therapy and risk of

Hormone replacement therapy and risk of epithelial ovarian cancer

✍ Purdie, D M; Bain, C J; Siskind, V; Russell, P; Hacker, N F; Ward, B G; Quinn, M 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Hormone Replacement Therapy and the Risk

Hormone Replacement Therapy and the Risk of Ovarian Cancer

✍ Harvey A. Risch 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Hormone replacement therapy and ovarian

Hormone replacement therapy and ovarian cancer risk – any news?

✍ TOMAS RIMAN 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 48 KB

Risks and Benefits of Hormone Replacemen

Risks and Benefits of Hormone Replacement Therapy

✍ Theodore A. Kotchen; George Mansour; Janette Mansour 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 126 KB

Breast cancer risk and hormone replaceme

Breast cancer risk and hormone replacement therapy

✍ David H. Barlow; Professor Michael Baum 📂 Article 📅 1999 🏛 Royal College of Obstetricians and Gynaecologists ⚖ 818 KB

Hormone replacement therapy and breast c

Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women

✍ Rui Li; Frank D. Gilliland; Kathy Baumgartner; Jonathan Samet 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Background: Hormone replacement therapy (hrt) alleviates menopausal symptoms and prevents osteoporosis, but there is concern that long-term use may have an adverse impact on breast carcinoma risk. epidemiologic studies report inconsistent findings regarding the relationship between hrt and postm